* Predictive Oncology Inc POAI.OQ POAI.O is expected
to report
resultson November 12 (estimated) for the period ending
September 30 2024
* The Pittsburgh Pennsylvania-based company is expected to
report
revenue of $500 thousand, according to the estimate from one
analyst, based on LSEG data.
* LSEG's mean analyst estimate for Predictive Oncology Inc
is for
a loss of 32 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Buy".
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $3.00, above its last closing price of $0.83.
This summary was machine generated November 8 at 16:33 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)